The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study

SIMPLE SUMMARY: Treatment of small HER2+ breast cancers with adjuvant Trastuzumab is still controversial. This study aims to measure the effect of Trastuzumab in early stages of breast cancer (pT1mic/a pN0/1mi) in terms of disease recurrence and to identify which factors most affect the prognosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Villasco, Andrea, Actis, Silvia, Bounous, Valentina Elisabetta, Borella, Fulvio, D’Alonzo, Marta, Ponzone, Riccardo, De Sanctis, Corrado, Benedetto, Chiara, Biglia, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616482/
https://www.ncbi.nlm.nih.gov/pubmed/34830989
http://dx.doi.org/10.3390/cancers13225836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616482/
https://www.ncbi.nlm.nih.gov/pubmed/34830989
http://dx.doi.org/10.3390/cancers13225836

Ejemplares similares